APTO Price Targets and Analyst Ratings NASDAQ:APTO
APTO Forecast. What You Should Know.
APTO Historical Ratings and Targets
About Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.